PRME financials
Prime Medicine (PRME) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
PRME income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $4.63M | -$2.69M | -$208.35M | -$201.14M | -1.35 |
| 2024 | $2.98M | $2.98M | -$202.47M | -$195.88M | -1.65 |
| 2023 | $0.00 | $0.00 | -$204.79M | -$198.13M | -2.18 |
| 2022 | $0.00 | $0.00 | -$116.54M | -$121.82M | -1.46 |
| 2021 | $0.00 | $0.00 | -$84.47M | -$165.37M | -1.92 |
| 2020 | $5.21M | $2.23M | -$932.00K | -$3.41M | -0.05 |
- PRME revenue was $4.63M in fiscal 2025, net income -$201.14M.
Updated 2026-11-07 11:53 UTC